Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$15.4 - $20.16 $4.22 Million - $5.52 Million
-273,734 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$18.24 - $21.45 $739,996 - $870,226
-40,570 Reduced 12.91%
273,734 $4.99 Million
Q1 2020

May 15, 2020

SELL
$16.28 - $25.63 $9.74 Million - $15.3 Million
-597,977 Reduced 65.55%
314,304 $6.33 Million
Q4 2019

Feb 14, 2020

BUY
$19.57 - $23.52 $595,652 - $715,878
30,437 Added 3.45%
912,281 $21.2 Million
Q3 2019

Nov 14, 2019

BUY
$19.85 - $22.76 $2.64 Million - $3.02 Million
132,770 Added 17.72%
881,844 $17.7 Million
Q2 2019

Aug 14, 2019

SELL
$17.59 - $21.1 $1.26 Million - $1.51 Million
-71,527 Reduced 8.72%
749,074 $15.8 Million
Q1 2019

May 15, 2019

BUY
$18.01 - $20.11 $28,221 - $31,512
1,567 Added 0.19%
820,601 $16.5 Million
Q4 2018

Feb 14, 2019

BUY
$17.44 - $21.53 $2.6 Million - $3.21 Million
148,900 Added 22.22%
819,034 $15 Million
Q3 2018

Nov 14, 2018

BUY
$19.97 - $21.96 $4.38 Million - $4.82 Million
219,326 Added 48.65%
670,134 $14.3 Million
Q2 2018

Aug 14, 2018

BUY
$20.16 - $24.68 $2.1 Million - $2.57 Million
104,125 Added 30.03%
450,808 $9.69 Million
Q1 2018

May 15, 2018

SELL
$20.31 - $24.95 $2.37 Million - $2.92 Million
-116,923 Reduced 25.22%
346,683 $7.35 Million
Q4 2017

Feb 14, 2018

BUY
$20.99 - $23.89 $2.05 Million - $2.33 Million
97,505 Added 26.63%
463,606 $10.6 Million
Q3 2017

Nov 14, 2017

BUY
$20.07 - $21.89 $7.35 Million - $8.01 Million
366,101
366,101 $8.01 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.33B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.